Showing results (1-10 of 52) with videos related to
Sort By:
Pageof 6
Current Oncology Reports|July 12, 2011
Treatment of acute lymphoblastic leukemia in adolescents and young adultsJoseph M BrandweinTherapeutic Advances in Hematology|April 2, 2015
Targeting polo-like kinase 1 in acute myeloid leukemiaJoseph M BrandweinAmerican Journal of Blood Research|January 31, 2019
Advances in biology of acute lymphoblastic leukemia (ALL) and therapeutic implicationsMahsa Mohseni, Hasan Uludag, Joseph M BrandweinBMC Infectious Diseases|June 27, 2013
Ambulatory consolidation chemotherapy for acute myeloid leukemia with antibacterial prophylaxis is associated with frequent bacteremia and the emergence of fluoroquinolone resistant E. ColiLalit Saini, Coleman Rostein, Eshetu G Atenafu, et al.Leukemia Research|May 7, 2013
CD13 expression is an independent adverse prognostic factor in adults with Philadelphia chromosome negative B cell acute lymphoblastic leukemiaKenneth J Craddock, Yan Chen, Joseph M Brandwein, et al.Cancer|December 20, 2011
Therapy-related acute lymphoblastic leukemia is more frequent than previously recognized and has a poor prognosisAmal Abdulwahab, Jenna Sykes, Suzanne Kamel-Reid, et al.Leukemia Research|November 9, 2013
Quality of life following completion of treatment for adult acute lymphoblastic leukemia with a pediatric-based protocolElena Liew, Santhosh Thyagu, Eshetu G Atenafu, et al.Leukemia Research|July 23, 2013
Differential survival improvement for patients 20-29 years of age with acute lymphoblastic leukemiaJason D Pole, Denise Darmawikarta, Shabbir M H Alibhai, et al.Drug Discovery Today|May 19, 2019
Current outlook on drug resistance in chronic myeloid leukemia (CML) and potential therapeutic optionsDaniel Nisakar Meenakshi Sundaram, Xiaoyan Jiang, Joseph M Brandwein, et al.Leukemia Research|July 19, 2023
Changing frontline AML treatment patterns from 2013 to 2022Joseph M Brandwein, Kurt Ebeling, Lei Ding, et al.Pageof 6